Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price hits fresh 52-week high at Rs 896.65
- August 26, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price moved to Rs 896.65 today, up 2.49% from the previous close of Rs 874.9, after touching a fresh 52-week high of Rs 904.95. The company’s market capitalisation stands at Rs 49,768.65 crore, placing the move in the context of a sizable listed healthcare name. This Anthem Biosciences Share Price update matters because it confirms a new yearly high on the day’s price range, even though the supplied data does not establish a company-specific catalyst. In other words, the event is clear, the price move is measurable and the broader analysis now turns to valuation, sector positioning and the company’s reported financial profile. For readers tracking Anthem Biosciences Share Price Today, the current session shows a narrow gap between the high and the last price, with turnover at Rs 2.61 crore.
Anthem Biosciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 896.65 |
| Previous Close | Rs 874.9 |
| Today's Move | +Rs 21.75 (+2.49%) |
| Open | Rs 876 |
| High | Rs 904.95 |
| Low | Rs 876 |
| Turnover | Rs 2.61 crore |
| Market Capitalisation | Rs 49,768.65 crore |
Anthem Biosciences Ltd. (ANTHEM) traded at Rs 896.65 versus the previous close of Rs 874.9, a rise of 2.49%. The stock opened at Rs 876, reached a high of Rs 904.95 and touched a low of Rs 876.
Anthem Biosciences Share Price Today opened at Rs 876 and later moved within a Rs 876 to Rs 904.95 band, with the day’s low matching the opening level and the high matching the fresh 52-week peak. The stock finished the session at Rs 896.65, which is Rs 21.75 above the previous close of Rs 874.9. That translates into a 2.49% rise for the day. The supplied turnover of Rs 2.61 crore gives a factual snapshot of traded value for the session, while the price range shows that the stock stayed above the opening level throughout the day. For anyone following Anthem Biosciences Share Price, the key takeaway is simple: the market registered a new yearly high, and the latest quote remained close to that intraday peak. Anthem Biosciences Stock News therefore centres on a confirmed 52-week high event rather than an identified trigger.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,768.65 crore |
| P/E Ratio | 85.59x |
| P/B Ratio | 15.75x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.55 |
| Dividend Yield | 0.23% |
Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 85.59x, P/B 15.75x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.
Anthem Biosciences Ltd. has a market capitalisation of Rs 49768.65 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 85.59x, P/B at 15.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.22, book value per share of Rs 55.55, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.32x, median ROE of 11.81%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 85.59x |
| Benchmark Median P/E | 30.32x |
| Benchmark Average P/E | 46.56x |
| Benchmark P/E Range | 2.94x to 717.81x |
| Company P/B Ratio | 15.75x |
| Benchmark Median P/B | 2.7x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 49,768.65 crore |
| Benchmark Median Market Cap | Rs 599.92 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 85.59x, which is above the benchmark median of 30.32x, a difference of +182.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.81%, a difference of +86.11%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.75%, a difference of +115.42%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 49,644.44 | 47.26 | 20.03 | 48.76 | 66.79 |
| Ipca Laboratories Ltd. | IPCALAB | 48,744.19 | 37.39 | 5.77 | 15.88 | 19.41 |
| Gland Pharma Ltd. | GLAND | 46,219.53 | 41.23 | 4.38 | 10.56 | 14.96 |
| Ajanta Pharma Ltd. | AJANTPHARM | 44,672.85 | 39.17 | 9.15 | 25.42 | 32.67 |
| Abbott India Ltd. | ABBOTINDIA | 56,131.84 | 34.79 | 10.85 | 34.67 | 46.72 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 85.59x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 49,768.65 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price closed at Rs 896.65 after touching Rs 904.95, a fresh 52-week high.
- The day’s move was Rs 21.75, or 2.49%, versus the previous close of Rs 874.9.
- Market capitalisation is Rs 49,768.65 crore, with EPS at Rs 10.22 and book value at Rs 55.55.
- P/E is 85.59 and P/B is 15.75, both above the supplied same-industry medians.
- ROE of 21.98% and ROCE of 29.62% are above the benchmark medians in the sector snapshot.
About Anthem Biosciences
Anthem Biosciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data places Anthem Biosciences Share Price within a large listed universe of healthcare and pharma companies. On the available company classification, Anthem Biosciences Stock News is best understood through its sector, industry and reported financial metrics rather than through any broader business narrative not provided in the data. Investors following Anthem Biosciences Share Price Today can use the company’s market cap, earnings, book value and sector benchmark to compare the stock with its listed peers.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Anthem Biosciences Share Price on Univest for live share price updates, shareholding pattern, company financials, market cap, 52-week levels, peer comparison and fundamental ratios. Univest also helps users review the stock’s latest news, company snapshot and sector context in one place. For Anthem Biosciences Share Price Today, Univest brings together price action, valuation and benchmark context so readers can follow the stock with a consistent research view.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Anthem Biosciences Share Price hit a fresh 52-week high?
Ans. The supplied data confirms that Anthem Biosciences Share Price touched Rs 904.95, a fresh 52-week high, and ended at Rs 896.65. It does not establish a company-specific catalyst for the move.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price today closed at Rs 896.65, up Rs 21.75 or 2.49% from the previous close of Rs 874.9. The stock also set a fresh yearly high during the session.
What is the 52-week high for Anthem Biosciences Share Price?
Ans. The fresh 52-week high for Anthem Biosciences Share Price is Rs 904.95. That level was reached during the day, while the closing price was slightly lower at Rs 896.65. The stock moved 2.49% during the session.
How expensive is Anthem Biosciences Share Price versus peers?
Ans. Anthem Biosciences Share Price trades at a P/E of 85.59 and P/B of 15.75. Both are above the supplied industry medians and above the P/E of the five listed peers in the comparison set.
What do Anthem Biosciences fundamentals show?
Ans. Anthem Biosciences Share Price is supported by ROE of 21.98%, ROCE of 29.62%, EPS of Rs 10.22 and book value of Rs 55.55. Dividend yield stands at 0.23% based on the supplied data.
How does Anthem Biosciences compare with the healthcare sector benchmark?
Ans. Anthem Biosciences Share Price stands above the same-industry median on P/E, P/B, ROE and ROCE. Its market cap of Rs 49,768.65 crore is also far above the industry median market cap of Rs 599.92 crore.
Which peers are used for Anthem Biosciences Share Price comparison?
Ans. The supplied peer set for Anthem Biosciences Share Price includes Glaxosmithkline Pharmaceuticals, Ipca Laboratories, Gland Pharma, Ajanta Pharma and Abbott India. Their market caps and valuation ratios provide a direct comparison base.
